Oct 3 (Reuters) – Danish drugmaker Novo Nordisk said it plans to make its new obesity pill available through telehealth platforms like Ro and WeightWatchers once it gets U.S. approval, Bloomberg News reported on Friday. (Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Beijing (dpa) - The number of women worldwide seeking medical help for fertility problems is…
By Matt Silverstein and Danielle Broadway LOS ANGELES, July 6 (Reuters) - For Australian actor…
Beijing (dpa) - There is a scientific explanation for why so-called "comfort eating" has the…
नई दिल्ली,7 जुलाई: ऑनलाइन गेमिंग की दुनिया लगातार विकसित हो रही है, और अब भारतीय…
By Paul Sandle and Sarah Young LONDON, July 6 (Reuters) - Comcast's Sky has agreed…
By Jonathan Stempel July 6 (Reuters) - A federal judge on Monday dismissed a lawsuit…